Literature DB >> 8115755

Gamma Knife surgery for cerebral metastases. Implications for survival based on 16 years experience.

L Kihlström1, B Karlsson, C Lindquist.   

Abstract

Our experience with radiosurgery of brain metastases is based on 160 patients with 235 tumors treated over a 16-year period. In this material, 94% growth control was achieved. Radiosurgery appears to be an effective, low-morbidity substitute for surgical resection followed by whole brain radiotherapy and even indicated for multiple metastases and distant new tumors. More patients receive an effective treatment with less neurologically related deaths.

Entities:  

Mesh：

Year:  1993        PMID： 8115755     DOI： 10.1159/000100659

Source DB:  PubMed          Journal:  Stereotact Funct Neurosurg        ISSN： 1011-6125            Impact factor:   1.875


  17 in total

Review 1.  Radiotherapy and chemotherapy of brain metastases.

Authors:  R Soffietti; A Costanza; E Laguzzi; M Nobile; R Rudà
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

2.  Outcomes and predictors of improved survival after gamma knife radiosurgery for metastatic brain tumors originated from breast carcinoma.

Authors:  Shyamal C Bir; Papireddy Bollam; Anil Nanda
Journal:  Neurosurg Rev       Date:  2015-04-07       Impact factor: 3.042

3.  Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy.

Authors:  Imjai Chitapanarux; Bryan Goss; Roy Vongtama; Leonardo Frighetto; Antonio De Salles; Michael Selch; Michael Duick; Timothy Solberg; Robert Wallace; Cynthia Cabatan-Awang; Judith Ford
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

4.  Characteristics of patients with brain metastases from lung cancer in a palliative care center.

Authors:  Ryuya Yamanaka; Hatsuyo Koga; Yousuke Yamamoto; Shinichi Yamada; Tomomi Sano; Tetsushi Fukushige
Journal:  Support Care Cancer       Date:  2010-03-10       Impact factor: 3.603

5.  Perspectives on stereotactic body radiotherapy for early-stage non-small cell lung cancer: a maturing treatment modality.

Authors:  Chunhui Han
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

6.  The role of stereotactic radiosurgery and whole brain radiation therapy as primary treatment in the treatment of patients with brain oligometastases - A systematic review.

Authors:  Or Cohen-Inbar; Jason P Sheehan
Journal:  J Radiosurg SBRT       Date:  2016

7.  Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer.

Authors:  Jin Sakamoto; Makoto Sonobe; Masashi Kobayashi; Masashi Ishikawa; Ryutaro Kikuchi; Daisuke Nakajima; Tetsu Yamada; Ei Nakayama; Tsuyoshi Takahashi; Toshihiko Sato; Fengshi Chen; Toru Bando; Hiroshi Date
Journal:  Int J Clin Oncol       Date:  2012-12-14       Impact factor: 3.402

8.  Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors.

Authors:  Donald A Ross; Howard M Sandler; James M Balter; James A Hayman; Paul G Archer; Donna L Auer
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

Review 9.  Treatment options for brain metastases in patients with non-small-cell lung cancer.

Authors:  Sadaf Taimur; Martin J Edelman
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.075

10.  Patient selection criteria for the treatment of brain metastases with stereotactic radiosurgery.

Authors:  K H Cho; W A Hall; B J Gerbi; P D Higgins; M Bohen; H B Clark
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.